Cargando…
Correction: Silencing LCN2 suppresses oral squamous cell carcinoma progression by reducing EGFR signal activation and recycling
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10134512/ https://www.ncbi.nlm.nih.gov/pubmed/37106361 http://dx.doi.org/10.1186/s13046-023-02679-0 |
| _version_ | 1785031779370926080 |
|---|---|
| author | Huang, Zixian Rui, Xi Yi, Chen Chen, Yongju Chen, Rui Liang, Yancan Wang, Yan Yao, Weicheng Xu, Xiaoding Huang, Zhiquan |
| author_facet | Huang, Zixian Rui, Xi Yi, Chen Chen, Yongju Chen, Rui Liang, Yancan Wang, Yan Yao, Weicheng Xu, Xiaoding Huang, Zhiquan |
| author_sort | Huang, Zixian |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10134512 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-101345122023-04-28 Correction: Silencing LCN2 suppresses oral squamous cell carcinoma progression by reducing EGFR signal activation and recycling Huang, Zixian Rui, Xi Yi, Chen Chen, Yongju Chen, Rui Liang, Yancan Wang, Yan Yao, Weicheng Xu, Xiaoding Huang, Zhiquan J Exp Clin Cancer Res Correction BioMed Central 2023-04-27 /pmc/articles/PMC10134512/ /pubmed/37106361 http://dx.doi.org/10.1186/s13046-023-02679-0 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
| spellingShingle | Correction Huang, Zixian Rui, Xi Yi, Chen Chen, Yongju Chen, Rui Liang, Yancan Wang, Yan Yao, Weicheng Xu, Xiaoding Huang, Zhiquan Correction: Silencing LCN2 suppresses oral squamous cell carcinoma progression by reducing EGFR signal activation and recycling |
| title | Correction: Silencing LCN2 suppresses oral squamous cell carcinoma progression by reducing EGFR signal activation and recycling |
| title_full | Correction: Silencing LCN2 suppresses oral squamous cell carcinoma progression by reducing EGFR signal activation and recycling |
| title_fullStr | Correction: Silencing LCN2 suppresses oral squamous cell carcinoma progression by reducing EGFR signal activation and recycling |
| title_full_unstemmed | Correction: Silencing LCN2 suppresses oral squamous cell carcinoma progression by reducing EGFR signal activation and recycling |
| title_short | Correction: Silencing LCN2 suppresses oral squamous cell carcinoma progression by reducing EGFR signal activation and recycling |
| title_sort | correction: silencing lcn2 suppresses oral squamous cell carcinoma progression by reducing egfr signal activation and recycling |
| topic | Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10134512/ https://www.ncbi.nlm.nih.gov/pubmed/37106361 http://dx.doi.org/10.1186/s13046-023-02679-0 |
| work_keys_str_mv | AT huangzixian correctionsilencinglcn2suppressesoralsquamouscellcarcinomaprogressionbyreducingegfrsignalactivationandrecycling AT ruixi correctionsilencinglcn2suppressesoralsquamouscellcarcinomaprogressionbyreducingegfrsignalactivationandrecycling AT yichen correctionsilencinglcn2suppressesoralsquamouscellcarcinomaprogressionbyreducingegfrsignalactivationandrecycling AT chenyongju correctionsilencinglcn2suppressesoralsquamouscellcarcinomaprogressionbyreducingegfrsignalactivationandrecycling AT chenrui correctionsilencinglcn2suppressesoralsquamouscellcarcinomaprogressionbyreducingegfrsignalactivationandrecycling AT liangyancan correctionsilencinglcn2suppressesoralsquamouscellcarcinomaprogressionbyreducingegfrsignalactivationandrecycling AT wangyan correctionsilencinglcn2suppressesoralsquamouscellcarcinomaprogressionbyreducingegfrsignalactivationandrecycling AT yaoweicheng correctionsilencinglcn2suppressesoralsquamouscellcarcinomaprogressionbyreducingegfrsignalactivationandrecycling AT xuxiaoding correctionsilencinglcn2suppressesoralsquamouscellcarcinomaprogressionbyreducingegfrsignalactivationandrecycling AT huangzhiquan correctionsilencinglcn2suppressesoralsquamouscellcarcinomaprogressionbyreducingegfrsignalactivationandrecycling |